An evaluation method for developing abuse-deterrent opioid formulations with agonist and antagonist combinations...

Area of Science:

• Pharmacology
• Neuroscience
• Drug Development

Background:

• Opioid misuse and addiction are significant global health crises.
• There is an urgent need for abuse-deterrent opioid formulations to mitigate addiction.
• Current formulations require improved strategies to prevent non-medical use.

Purpose of the Study:

• To investigate optimal ratios of opioids and naloxone for abuse-deterrent formulations.
• To evaluate the efficacy of the conditioned place preference (CPP) test in assessing abuse potential.
• To establish a method for calculating effective antagonist-to-opioid ratios.

Main Methods:

• Utilized the conditioned place preference (CPP) test in mice to assess drug-induced rewarding effects.
• Administered various opioids (morphine, oxycodone, fentanyl, buprenorphine) and determined their ability to induce place preference.
• Determined effective doses of naloxone required to inhibit opioid-induced place preference.

Main Results:

• Morphine, oxycodone, fentanyl, and buprenorphine significantly induced place preference in mice.
• Naloxone effectively inhibited the rewarding effects of these opioids at specific doses.
• Calculated theoretical drug doses based on receptor binding and blood-brain barrier permeability closely matched observed effective doses.

Conclusions:

• The CPP test is a valuable behavioral model for evaluating abuse-deterrent opioid formulations.
• The determined ratios of naloxone to opioids can serve as an index for developing safer formulations.
• This approach allows for the calculation of effective ratios for other opioids based on their pharmacological properties.